PGMI-004A,1313738-90-7

MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

PGMI-004A

CAS No. : 1313738-90-7

MCE 国际站：PGMI-004A

产品活性：PGMI-004A 是一种有效的磷酸甘油酸变位酶 1 (PGAM1) 抑制剂，IC₅₀ 为 13.1 μM。

研究领域：Metabolic Enzyme/Protease

作用靶点：Phosphatase

In Vitro: PGMI-004A inhibits PGAM1 with an IC₅₀ of approximately 13.1 μM and the K_d value of the PGMI-004A-PGAM1 interaction is determined to be 7.2±0.7 μM from fluorescence-based binding assay. PGMI-004A may allosterically modulate the enzyme activity of PGAM1. The K_i value is determined to be 3.91±2.50 μM using Dixon plot analysis. The K_d value for protein-ligand interaction is calculated to be 9.4±2.0 μM. Inhibition of PGAM1 activity by PGMI-004A (20 μM) treatment results in decreased 2-PG and increased 3-PG levels in H1299 cells, which could be rescued by treatment with methyl-2-PG. Treatment with PGMI-004A (20 μM) results in significantly reduced lactate production that is rescued by methyl-2-PG treatment, but has no significant effect on intracellular ATP levels. PGMI-004A (20 μM) treatment results in decreased oxidative PPP flux and NADPH/NADP+ratio, as well as reduced biosynthesis of lipids and RNA, and cell proliferation in H1299 cells. PGMI-004A treatment results in decreased cell proliferation of diverse human cancer and leukemia cells, but not control human dermal fibroblasts (HDF), human foreskin fibroblasts (HFF), human HaCaT keratinocyte cells and human melanocyte PIG1 cells, suggesting minimal non-specific toxicity of PGMI-004A in normal, proliferating human cells.

In Vivo: The xenograft experiment is performed by injecting H1299 cells to nude mice. Six days post-injection, mice are divided into two groups (n=8/group) and treated with either PGMI-004A (100mg/kg/day) or vehicle for 21 days. PGMI-004A treatment results in significantly decreased tumor growth and tumor size in treated mice compared with mice receiving vehicle control. Moreover, treatment with PGMI-004A effectively inhibits PGAM1 enzyme activity in tumors in vivo in resected tumors from xenograft nude mice.

相关产品：Natural Product-like Compound Library  |  Bioactive Compound Library Plus  |  Metabolism/Protease Compound Library  |  Anti-Cancer Compound Library  |  Glycolysis Compound Library  |  Anti-Blood Cancer Compound Library  |  Phosphatase Inhibitor Library  |  Anti-Cancer Metabolism Compound Library  |  Glucose Metabolism Compound Library  |  Cyclosporin A  |  Tacrolimus  |  SHP099  |  Calyculin A  |  β-Glycerophosphate disodium salt pentahydrate  |  Salubrinal  |  Okadaic acid  |  Ebselen  |  Batoprotafib  |  L-Ascorbic acid 2-phosphate trisodium  |  Sodium orthovanadate  |  Suramin sodium salt  |  RMC-4550  |  TPI-1  |  Vociprotafib  |  Osunprotafib  |  DT-061  |  GSK 2830371  |  Sodium metatungstate  |  Idoxuridine  |  SF1670  |  NSC 663284  |  MSI-1436 lactate  |  BCI  |  D-erythro-Sphingosine  |  NSC-87877  |  Razuprotafib

热门产品线：重组蛋白  |  化合物库  |  天然产物  |  荧光染料  |  PROTAC  |  同位素标记物

Trending products：Recombinant Proteins  |  Bioactive Screening Libraries  |  Natural Products  |  Dye Reagents  |  PROTAC  |  Isotope-Labeled Compounds